Over the past few years, weight loss medications have become very popular, thanks in part to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1RAs)
That is useful for some applications but dangerous for others, particularly in people with cancer risk factors or metabolic disorders
If you have insurance, prioritize providers that assist with prior authorization
The variance seen in outcomes of alcohol consumption during pregnancy is poorly understood
Evidence from weight loss research suggests this hormonal shift may partially offset the appetite-suppressing effects of retatrutide, particularly during periods of significant weight loss
The post says that regardless of which agent or formulation is chosen, a provider needs to assess baseline metabolic health, screen for contraindications, and monitor for side effects